Homecoming Line: Telephone Support for Veterans (HCL)

January 12, 2016 updated by: Craig S. Rosen, Ph.D., VA Palo Alto Health Care System
This study will determine whether telephone support improves clinical outcomes of veterans who begin outpatient treatment for posttraumatic stress disorder. Participants will be randomly assigned to receive either usual care or usual care supplemented by biweekly monitoring and support by telephone during the first 3 months of treatment. Patients in both conditions will be compared on PTSD symptoms, engagement in treatment, violence and drinking at 4 months and 12 months after entering treatment.

Study Overview

Detailed Description

This multisite randomized controlled trial will test whether a 3-month period of providing telephone monitoring to PTSD patients as a supplement to usual specialty mental health care improves 12-month clinical outcomes (a reduction in PTSD symptoms, violence, and substance use). Secondarily, this study will determine whether telephone monitoring promotes better engagement in outpatient treatment (Number of mental health and psychotherapy visits during the 3-month intervention period).

Demand for VA PTSD treatment is increasing as troops return from combat deployments in Afghanistan and Iraq. Telemedicine is likely to be an important component in developing more effective and efficient models of PTSD care that improves patient functioning and treatment utilization. It is hoped that using telephone case monitoring as an inexpensive adjunct to standard care may improve clinical outcomes and reduce hospitalization among veterans with PTSD.

Study Type

Interventional

Enrollment (Actual)

358

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Menlo Park, California, United States, 94025
        • VA Palo Alto Health Care System (Meno Park Division)
    • North Carolina
      • Durham, North Carolina, United States, 27705
        • Durham VA Medical Center
    • Washington
      • Lakewood, Washington, United States, 98493
        • VA Puget Sound Health Care System (American Lake)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • VA patients newly entering outpatient treatment mental health treatment for PTSD starting a new phase of outpatient PTSD treatment (e.g., transitioning from a psycho-education group to active psychotherapy) at one of the study sites.

Exclusion Criteria:

  • Active duty personnel
  • Cognitive impairment which precludes giving informed consent
  • Initiating residential or inpatient treatment rather than outpatient treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Telephone Case Monitoring
Telephone care management augmenting treatment as usual
Outpatient mental health treatment as usual (normal case management, psychotherapy and/or pharmacotherapy) augmented by up to six fortnightly telephone monitoring and support calls from a case manager during the first three months of treatment.
Outpatient mental health treatment as usual (normal case management, psychotherapy and/or pharmacotherapy).
Active Comparator: Treatment as Usual
Case management, psychotherapy, and pharmacotherapy as usual
Outpatient mental health treatment as usual (normal case management, psychotherapy and/or pharmacotherapy).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD Checklist (PCL) Slope
Time Frame: 12 months
Slope of improvement on the PTSD Checklist, a self-report measure of PTSD symptoms.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
PTSD psychotherapy visits - intervention period
Time Frame: 3 months
Number of psychotherapy visits for PTSD (psychotherapy procedure code + PTSD diagnosis code) completed during the 3 month intervention period.
3 months
Other mental health visits - intervention period
Time Frame: 3 months
Number of "other" mental health visits (mental health visits without psychotherapy procedure code and/or without a PTSD diagnosis code) completed during the 3 month intervention period.
3 months
Depression slope
Time Frame: 12 months
Slope of improvement on the Center for Epidemiological Studies Scale, a self-report measure of depression symptoms.
12 months
Alcohol problems slope
Time Frame: 12 months
Slope of improvement on the Addiction Severity Index Alcohol Composite, a self-report measure of alcohol-related problems.
12 months
Drug problems slope
Time Frame: 12 months
Slope of improvement on the Addiction Severity Index Drug Composite, a self-report measure of drug-related problems.
12 months
Aggression slope
Time Frame: 12 months
Slope of improvement on a six-item self-report measure of aggressive behaviors, adapted from the Conflict Tactics Scale.
12 months
Quality of Life slope
Time Frame: 12 months
Slope of improvement on a self-report quality measure used in the Veterans Affairs Military Stress Treatment Assessment study.
12 months
PTSD psychotherapy visits -- follow-up period
Time Frame: months 4-12
Number of psychotherapy visits for PTSD (psychotherapy procedure code + PTSD diagnosis code) completed during the post-intervention period (months 4-12).
months 4-12
Other mental health visits -- follow-up period
Time Frame: months 4-12
Number of "other" mental health visits (mental health visits without psychotherapy procedure code and/or without a PTSD diagnosis code) completed during the post-intervention period (months 4-12).
months 4-12
Selective serotonin reuptake inhibitor refills (medication possession ratio)
Time Frame: 12 months
Number of days' supply of selective serotonin reuptake inhibitors (SSRIs) obtained divided by 365 days.
12 months
Prazosin refills (medication possession ratio)
Time Frame: 12 months
Number of days' supply of Prazosin obtained divided by 365 days.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Craig S. Rosen, Ph.D., VA Palo Alto Health Care System

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Actual)

August 1, 2014

Study Completion (Actual)

August 1, 2014

Study Registration Dates

First Submitted

January 12, 2016

First Submitted That Met QC Criteria

January 12, 2016

First Posted (Estimate)

January 14, 2016

Study Record Updates

Last Update Posted (Estimate)

January 14, 2016

Last Update Submitted That Met QC Criteria

January 12, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress Disorders, Post-Traumatic

Clinical Trials on Telephone Case Monitoring

3
Subscribe